|
|
Line 12: |
Line 12: |
|
| |
|
| =Public Health Advantages / Concerns of Public Health Harms= | | =Public Health Advantages / Concerns of Public Health Harms= |
| | |
| | |
| | ===2020: [https://pubmed.ncbi.nlm.nih.gov/32881666/ Investigation on the antibacterial activity of electronic cigarette liquids (ECLs): a proof of concept study]=== |
| | *Our results have shown that flavors considerably enhance antibacterial activity. |
| | *This study provides important evidence that should be taken into consideration in further investigative approaches, to clarify the different sensitivity of the various bacterial species to e-liquids, including the respiratory microbiota, to highlight the possible role of flavors and nicotine. |
| | *Citation: Virginia Fuochi, Massimo Caruso , Rosalia Emma, Aldo Stivala, Riccardo Polosa, Alfio Distefano and Pio Maria Furneri *, “Investigation on the Antibacterial Activity of Electronic Cigarette Liquids (ECLs): A Proof of Concept Study”, Current Pharmaceutical Biotechnology (2020) 21: 1. doi:10.2174/1389201021666200903121624 |
|
| |
|
|
| |
|